Fidelity SPDR Advertisement
Home > Boards > US OTC > Medical - Drugs > Artec, Inc (ATKJ)

Re that sham HTDS Tubercin patent filing:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
nanopatent Member Profile
Member Level 
Followed By 91
Posts 20,034
Boards Moderated 5
Alias Born 02/01/04
160x600 placeholder
nanopatent Member Level  Thursday, 09/21/06 06:19:34 PM
Re: None
Post # of 4971 
Re that sham HTDS Tubercin patent filing:
Chung et al. isolated from M. tuberculosis a substance having an anticancer activity and used this substance, designated as Tubercin-3, in treating terminal-cancer and leprosy patients as well as laboratory animals suffering from tumoral symptoms [Chung, T. H., J. Korean Med. Ass., 17, 427-431(1974); Chung, T. H. et al., Yonsei Med. J., 17, 131-135(1976)].

From US patent 6,274,356 Chung, et al., August 14, 2001
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fne...

Leprosy is a bacterial infection!

So - Tubercin is effective on cancer AND bacterial infections. To extend that teaching to include viral infection as well seems no big deal to me - certainly NOT an inventive step. Ask Shapiro! He's willing to take $30K and run. he knows the score!!!!

The SEC Must Go!
And jail shorters.



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist